Page 1 2 ... 30 40 50 ... 200 ... NEXT>>
[ December 21, 2014 | Author: admin | Views: 50018 | Weather: | Mood: normal]

John Abele, cofounder of Boston Scientific, a pioneer developer of medical devices and a former member of The Forbes 400, leaves his front door with its dragonfly knocker unlocked. He welcomes me into the unpretentious frame house he and his wife, Mary, built on a knoll of Meach Cove Farms, a 1,000-acre Shelburne, Vt. property they bought in 1997. The picture windows frame a rolling landscape planted with maple trees and organic soybean and hay, leading down to a half-mile of Lake Champlain waterfront, with the Adirondack Mountains in the distance. A breeze sets off dolphin-shaped chimes in the great room. Looking comfortable in a blue open-collar shirt, khakis and low Merrell hikers with no socks, Abele settles into an overstuffed flower-upholstered armchair. But hes not relaxing for long. Since retiring from Boston Scientific in 2005, the now 77-year-old Abele has engaged in a busy second career of philanthropy, venture … Continue reading

[ December 21, 2014 | Author: admin | Views: 45351 | Weather: | Mood: normal]

Celgene (NASDAQ: CELG  ) was one of several companies presenting at the American Society of Clinical Oncology, or ASCO, annual meeting in Chicago this week. Here’s what the big biotech had to say. Ho-hum for AbraxaneFindings from a phase 3 study of Abraxane in combination with gemcitabine in the treatment of advanced pancreatic cancer were presented on Sunday and Monday. The open-label study — known as the Metastatic Pancreatic Adenocarcinoma Clinical Trial, or MPACT — included 861 metastatic pancreatic cancer patients. The first key result discussed related to the first 257 patients in the study to be independently evaluated using positron emission tomography, or PET, scans. 63% of the patients taking Abraxane with gemcitabine had a metabolic response compared to 38% of patients taking gemcitabine alone. The patients in the Abraxane group also had a median overall survival rate of 10.5 months versus 8.3 months for patients taking only gemcitabine. Another … Continue reading

[ December 21, 2014 | Author: admin | Views: 78027 | Weather: | Mood: normal]

With shares of Boeing (NYSE:BA) trading around $103, is BA an OUTPERFORM, WAIT AND SEE or STAY AWAY? Lets analyze the stock with the relevant sections of our CHEAT SHEET investing framework: T = Trends for a Stock’s Movement Boeing is an aerospace company. The company operates in five segments: Commercial Airplanes, Boeing Military Aircraft, Network & Space Systems, Global Services & Support, and Boeing Capital Corporation. It focuses primarily on engineering, information technology, research and development, test and evaluation, technology strategy development, environmental remediation management and intellectual property management. As a leading provider of aerospace products and services to large corporations, including the United States Government, look for Boeing to continue to advance and develop this space and fuel aerial progress. NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW! T = Technicals … Continue reading

[ December 21, 2014 | Author: admin | Views: 66442 | Weather: | Mood: normal]

Watch Iron Man 3 closely enough and you’ll find two references to Oracle (NYSE: ORCL  ) , the database giant that’s had trouble diversifying into hardware. Will associating with a billionaire computer genius — even a fictional one — aid sales? CEO Larry Ellison seems to think so. The first time Oracle appears in the film, Tony Stark asks computer assistant J.A.R.V.I.S to help him narrow a national search for clues to a crime, after which the Paul Bettany-voiced system responds that it had “engaged the Oracle cloud.” The second time, a “Sun-Oracle” sign appears above Stark as he prepares to reconfigure the Internet signal of a satellite truck. We’ve seen this before: Ellison appears as himself early in Iron Man 2. And why not? Ellison, like Stark, is a brash billionaire heading a tech empire. The difference is that Oracle is taking risky bets to overcome stiff competition from … Continue reading

[ December 21, 2014 | Author: admin | Views: 54645 | Weather: | Mood: normal]

U.S. stock futures traded mostly higher Thursday. Dow Jones industrial average index futures rose 0.3%, Standard & Poor’s 500 index futures were up 0.3%. Nasdaq index futures fell 0.2%. On Wall Street, markets hit record highs Wednesday. The S&P 500 index rose 0.8% to 1,782. The Dow gained 0.5% to 15,821.63. The Nasdaq climbed 1.2% to 3,965.58. WEDNESDAY: Dow, S&P 500 hit new closing highs Asian stock markets bounced higher Thursday after prepared testimony for the confirmation hearing of incoming Federal Reserve chief Janet Yellen suggested the U.S. central bank won’t reduce its economic stimulus until March next year or later. Tokyo’s Nikkei 225 surged 2.1% to 14,876.41. In Europe, most major benchmarks advanced around 1% even though official figures showed that the region’s recovery from recession in the 17-country eurozone continued in the third-quarter of the year but only just. Top 5 US Companies To Buy Right N ow: … Continue reading